Biomarkers for sepsis: past, present and future

Submitted: 6 October 2016
Accepted: 20 October 2016
Published: 15 December 2016
Abstract Views: 2368
PDF: 1054
HTML: 1150
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.


Sepsis is a complication of severe infection associated with high mortality and open diagnostic issues. Treatment strategies are currently limited and essentially based on prompt recognition, aggressive supportive care and early antibiotic treatment. In the last years, extensive antibiotic use has led to selection, propagation and maintenance of drug-resistant microorganisms. In this context, several biomarkers have been proposed for early identification, etiological definition, risk stratification and improving antibiotic stewardship in septic patient care. Among these molecules, only a few have been translated into clinical practice. In this review, we provided an updated overview of established and developing biomarkers for sepsis, focusing our attention on their pathophysiological profile, advantages, limitations, and appropriate evidence-based use in the management of septic patients.



PlumX Metrics


Download data is not yet available.


How to Cite

Chesi, G., Vazzana, N., & Giumelli, C. (2016). Biomarkers for sepsis: past, present and future. Italian Journal of Medicine, 10(4), 301–307.

Similar Articles

You may also start an advanced similarity search for this article.

List of Cited By :

Crossref logo